HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.

Abstract
The antibiotic GE2270A prevents stable complex formation between elongation factor Tu (EF-Tu) and aminoacyl-tRNA (aatRNA). In Escherichia coli we characterized two mutant EF-Tu species with either G257S or G275A that lead to high GE2270A resistance in poly(Phe) synthesis, which at least partially explains the high resistance of EF-Tu1 from GE2270A producer Planobispora rosea to its own antibiotic. Both E. coli mutants were unexpectedly found to bind GE2270A nearly as well as wild-type (wt) EF-Tu in their GTP-bound conformations. Both G257S and G275A are in or near the binding site for the 3' end of aatRNA. The G257S mutation causes a 2.5-fold increase in affinity for aatRNA, whereas G275A causes a 40-fold decrease. In the presence of GE2270A, wt EF-Tu shows a drop in aatRNA affinity of at least four orders of magnitude. EF-Tu[G275S] and EF-Tu[G275A] curtail this drop to about two or one order, respectively. It thus appears that the resistance mutations do not prevent GE2270A from binding to EF-Tu.GTP and that the mutant EF-Tus may accommodate GE2270A and aatRNA simultaneously. Interestingly, in their GDP-bound conformations the mutant EF-Tus have much less affinity for GE2270A than wt EF-Tu. The latter is explained by a recent crystal structure of the EF-Tu.GDP.GE2270A complex, which predicts direct steric problems between GE2270A and the mutated G257S or G275A. These mutations may cause a dislocation of GE2270A in complex with GTP-bound EF-Tu, which then no longer prevents aatRNA binding as in the wt situation. Altogether, the data lead to the following novel resistance scenario. Upon arrival of the mutant EF-Tu.GTP.GE2270.aatRNA complex at the ribosomal A-site, the GTPase centre is triggered. The affinities of aatRNA and GE2270A for the GDP-bound EF-Tu are negligible; the former stays at the A-site for subsequent interaction with the peptidyltransferase centre and the latter two dissociate from the ribosome.
AuthorsA M Zuurmond, J Martien de Graaf, L N Olsthoorn-Tieleman, B Y van Duyl, V G Mörhle, F Jurnak, J R Mesters, R Hilgenfeld, B Kraal
JournalJournal of molecular biology (J Mol Biol) Vol. 304 Issue 5 Pg. 995-1005 (Dec 15 2000) ISSN: 0022-2836 [Print] Netherlands
PMID11124042 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2000 Academic Press.
Chemical References
  • Aminoglycosides
  • Anti-Bacterial Agents
  • Peptides
  • Peptides, Cyclic
  • RNA, Bacterial
  • RNA, Transfer, Amino Acyl
  • Thiazoles
  • pulvomycin
  • Guanosine Diphosphate
  • Poly U
  • polyphenylalanine
  • Guanosine Triphosphate
  • Peptide Elongation Factor Tu
  • Adenine
  • GE 2270 A
Topics
  • Actinomycetales (chemistry)
  • Adenine (metabolism)
  • Amino Acid Substitution (genetics)
  • Aminoglycosides
  • Anti-Bacterial Agents (chemistry, pharmacology)
  • Drug Resistance, Microbial
  • Escherichia coli (chemistry, drug effects, genetics)
  • Guanosine Diphosphate (metabolism)
  • Guanosine Triphosphate (metabolism)
  • Models, Molecular
  • Mutation (genetics)
  • Peptide Elongation Factor Tu (chemistry, genetics, metabolism)
  • Peptides (metabolism)
  • Peptides, Cyclic (chemistry, pharmacology)
  • Poly U (genetics, metabolism)
  • Protein Binding (drug effects)
  • Protein Biosynthesis (drug effects)
  • Protein Conformation
  • RNA, Bacterial (genetics, metabolism)
  • RNA, Transfer, Amino Acyl (genetics, metabolism)
  • Thermodynamics
  • Thermus (chemistry)
  • Thiazoles (chemistry, metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: